• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃激活诱导的凝血酶原复合物先天性凝血障碍中正常凝血酶原时间-凝血酶时间差异的降低或消失。

Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.

作者信息

Girolami A, Patrassi G, Fabris F

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(2):283-93.

PMID:69593
Abstract

Exposure of plasma to glass for 60 minutes will cause a sharp, progressive shortening of Thrombotest clotting times in all congenital disorders of the prothrombin complex. On the other hand Normotest clotting times will change only slightly or moderately after the same glass activation. Consequently the Normotest-Thrombotest percentile discrepancy, quite marked at zero time, became progressively smaller. This behaviour is similar to that observed in a group of coumarin treated patients. These studies indicate that the Normotest/Thrombotest discrepancy does not allow any differentiation to be made between congenital coagulation disorders and coumarin induced defect. This is consistent with the non-specificity of the phenomenon.

摘要

血浆与玻璃接触60分钟会导致在所有凝血酶原复合物先天性疾病中,凝血酶检测的凝血时间急剧、逐渐缩短。另一方面,在相同的玻璃激活后,正常检测的凝血时间只会有轻微或中等程度的变化。因此,正常检测-凝血酶检测百分位数差异在零时相当显著,随后逐渐变小。这种行为与在一组接受香豆素治疗的患者中观察到的行为相似。这些研究表明,正常检测/凝血酶检测差异无法区分先天性凝血障碍和香豆素诱导的缺陷。这与该现象的非特异性是一致的。

相似文献

1
Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.玻璃激活诱导的凝血酶原复合物先天性凝血障碍中正常凝血酶原时间-凝血酶时间差异的降低或消失。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(2):283-93.
2
Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.
Blut. 1976 Jul;33(1):41-8. doi: 10.1007/BF01005211.
3
Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.凝血酶原复合物先天性凝血障碍及香豆素治疗患者中正常凝血试验与血栓形成试验的差异:一种非特异性现象。
Am J Clin Pathol. 1977 Jan;67(1):57-60. doi: 10.1093/ajcp/67.1.57.
4
Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.凝血酶原复合物先天性凝血障碍患者及香豆素治疗患者的凝血酶试验混合实验。这是反对后者存在抑制剂的又一证据。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(3):463-70.
5
Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.随着抗凝作用增强,稀释曲线系统中“抑制作用”明显降低。这是一个与香豆素治疗患者中存在抑制剂相悖的悖论。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(5):670-6.
6
[Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].肝速凝——一种新的凝血酶原时间系统:与正常凝血时间测定法和血栓试验的比较(作者译)
Wien Klin Wochenschr. 1974 Oct 18;86(19):577-83.
7
Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.在香豆素治疗患者的随访中进行的发色底物(S-2222)因子X测定。与凝血酶原时间和/或血栓试验相比无优势。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(4):610-6.
8
[Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].[凝血过程外源性途径研究中的奎克时间及衍生时间。慢性弥散性血管内凝血状态下的异常凝血酶原(维生素K缺乏或拮抗剂诱导蛋白)]
Quad Sclavo Diagn. 1974 Dec;10(4):463-73.
9
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
10
The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.口服抗凝治疗患者中正常凝血酶原时间测定与凝血酶时间测定的关系。
Scand J Haematol. 1977 Apr;18(4):333-6. doi: 10.1111/j.1600-0609.1977.tb01204.x.

引用本文的文献

1
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.